| View |
|
DRP-12383-02
|
Spironolactone
|
Spirophil
|
25 mg
|
Film-Coated Tablet
|
Diuretic (Aldosterone Antagonist)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
20 October 2022
|
29 July 2027
|
| View |
|
DRP-10624-01
|
Sitagliptin (as phosphate)
|
Januglip 50
|
50 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
11 February 2022
|
28 October 2026
|
| View |
|
DRP-11087-02
|
Co-Amoxiclav
|
Valcimox DS
|
457 mg/ 5 mL
|
Powder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Penicillin/Beta Lactamase Inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
29 March 2022
|
03 February 2027
|
| View |
|
DRP-10929-09
|
Norepinephrine (As Bitartrate)
|
Norifree
|
1mg/mL (4mg/4mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
16 June 2022
|
31 January 2027
|
| View |
|
DRP-10091-02
|
Norepinephrine (As Bitartrate)
|
Noreph
|
1 mg/mL (4 mg/4 mL)
|
Solution for I.V. Injection
|
-
|
Aju Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
07 December 2021
|
21 October 2025
|
| View |
|
DRP-4184-11
|
Paracetamol
|
Unbranded
|
500 mg
|
Tablet
|
Analgesic/Antipyretic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
22 March 2023
|
08 January 2028
|
| View |
|
DRP-10898-02
|
Losartan potassium + Hydrochlorothiazide
|
None
|
50 mg/12.50
|
Film Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Diuretic
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 October 2022
|
13 December 2026
|
| View |
|
DRP-12340-01
|
Olmesartan medoxomil
|
Olmephil 10
|
10 mg
|
Film-Coated Tablet
|
Angiotensin II receptor blocker (ARB)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
31 August 2022
|
20 July 2027
|
| View |
|
DRP-6955-04
|
Meropenem (as trihydrate)
|
Merodex II
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
BCWorld Healthcare Co., Ltd.
|
Korea
|
CLIDP Conversion
|
30 August 2022
|
04 January 2027
|
| View |
|
DRP-11355-01
|
Sevelamer Carbonate
|
Sefos
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 August 2022
|
03 March 2027
|
| View |
|
DRP-11154-08
|
Nicardipine Hydrochloride
|
Nicargio
|
1 mg/mL (10 mg/10 mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
21 July 2022
|
11 February 2027
|
| View |
|
DRP-10475-01
|
Telmisartan
|
Mevo 40
|
40 mg
|
Tablet
|
-
|
Globela Pharma Private Limited
|
Philippines
|
CLIDP Conversion
|
07 January 2022
|
30 September 2026
|
| View |
|
DRP-9073-01
|
Adapalene + Clindamycin (as phosphate)
|
Acneclear-C
|
10 mg/1 mg per g (1 w/w/0.1% w/w)
|
Topical Gel
|
Anti-acne (Lincosamide/Naphthoic Acid Derivative)
|
Curetech Skincare
|
India
|
CLIDP Conversion
|
22 August 2022
|
12 August 2025
|
| View |
|
DRP-9872-01
|
Iron + Riboflavin (Vitamin B2) + Cyanocobalamin (Vitamin B12) + Folic Acid
|
Hemaquest
|
165 mg/ 2 mg/ 3 mcg/ 230 mcg
|
Capsule
|
Anti-Anemic
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
09 August 2022
|
13 December 2026
|
| View |
|
DRP-10868-05
|
Ascorbic Acid + Zinc
|
Retazinc
|
533.40 mg (equivalent to 600mg Sodium Ascorbate) + 10 mg (equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
VITAMIN/MINERAL
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
08 July 2022
|
30 October 2025
|
| View |
|
DRP-6950-04
|
Cefoperazone (as Sodium) + Sulbactam (as Sodium)
|
Vaczucef
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin-Beta-Lactamase Inhibitor Combination)
|
BioRx Pharma Labs LLP
|
India
|
CLIDP Conversion
|
11 April 2022
|
14 December 2026
|
| View |
|
DRP-9079-02
|
Sitagliptin (as phosphate)
|
Sitaphil
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
21 July 2022
|
31 October 2025
|
| View |
|
DRP-10868-11
|
Ascorbic Acid + Zinc
|
South Star Cee
|
533.40 mg (equivalent to 600mg Sodium Ascorbate) + 10 mg (equivalent to 27.45 mg Zinc Sulfate)
|
Capsule
|
Vitamin/Mineral
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
19 October 2022
|
30 October 2025
|
| View |
|
DRP-10512-08
|
Febuxostat
|
Altoxustat 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 March 2022
|
07 October 2026
|
| View |
|
DRP-7406-03
|
Metformin Hydrochloride
|
Gludin
|
500 mg
|
Film-coated Tablet
|
Oral Hypoglycemic
|
Hizon Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 August 2022
|
12 January 2027
|